Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor![](https://www.oaklins.com/uploads/sites/10/2022/03/HEALTHCARE-detail.2022.jpg)
A group of Chilean investors has acquired Farmacias Ahumada
A group of Chilean investors has acquired Farmacias Ahumada S.A. from Walgreens Boots Alliance.
Learn moreLaboratorios Saval S.A. has acquired a pharmeceutical processing plant
Laboratorios Saval S.A. has acquired a pharmeceutical processing plant in Costa Rica from Laboratorios Stein S.A.
Learn moreProcaps S.A. has raised funds
Procaps S.A. has closed a club deal bank facility in a transaction financed by Bancolombia S.A. and Banco Davivienda S.A. The funds will be designated for the refinancing of existing debts owed to current creditors. This strategic allocation will empower the company to navigate its growth plan with enhanced financial strength.
Learn more![](/api/deal-client-photo/109552/deal-client-photo.jpeg)
Jan-Frederik Kolthoff
Founder and CEO, move UP Gesellschaft für Gesundheitsmanagement mbH
Read more![](/api/deal-client-logo/109552/deal-client-logo.png)
Reshaping industries: M&A highlights and strategic vision
QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the adaptability of various industries to evolving market conditions and strategic imperatives.
Learn more![](https://d21buns5ku92am.cloudfront.net/68798/images/544504-q2%202024%20hero-0fafbe-large-1719927574.jpg)
Talk to our local advisors
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital